ADAPY · OTC
It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.
Hover or tap a dot to see the filings behind that score.
Adaptimmune Therapeutics plc (the “Registrant” or the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Form 10-K”) because the Company needs additional time to prepare and review certain information and complete its review of its financial statements and other disclosures in the Form 10-K which could not be completed by March 1, 2022 without incurring unreasonable effort and expense. The delay is due to turnover and unanticipated absences in the finance department affecting the general review process and has not permitted the Company’s independent registered public accounting firm to complete their audit and report on the financial statements by March 1, 2022. The Company anticipates that it will file its Form 10-K as soon as reasonably possible and within the 15-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended
NT 10-K, filed 2022-03-01 · auditor
Adaptimmune Therapeutics plc (the “Registrant” or the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Form 10-K”) because the Company needs additional time to prepare and review certain information and complete its review of its financial statements and other disclosures in the Form 10-K which could not be completed by March 1, 2022 without incurring unreasonable effort and expense. The delay is due to turnover and unanticipated absences in the finance department affecting the general review process and has not permitted the Company’s independent registered public accounting firm to complete their audit and report on the financial statements by March 1, 2022. The Company anticipates that it will file its Form 10-K as soon as reasonably possible and within the 15-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice